Few Parents Know About CBD Use In Children
Tue / Mar 8th
A recent poll found that less than half of U.S. parents know much about the use of CBD products with regard to children and most have never tried CBD themselves.
The latest news about scientific research related to cannabis. To read academic medical studies that have been conducted in the past, check out our medical cannabis resources page. For more cannabis news and research updates, subscribe to our daily newsletter!
Tue / Mar 8th
A recent poll found that less than half of U.S. parents know much about the use of CBD products with regard to children and most have never tried CBD themselves.
Thu / Feb 17th
A recent survey found that cannabis consumers have more sex than non-consumers. Additionally, 65% of sexually active cannabis consumers agree that the plant enhances their sex life and helps them get in the mood for sex.
Thu / Feb 10th
A new study published in the American Journal of Preventive Medicine found that two in five drivers who reported using alcohol and cannabis in the past year drove under the influence.
Tue / Feb 8th
A new study has found that at least half of participants who smoke cannabis had a significantly diminished ability to drive compared to subjects who smoked a placebo cigarette.
Mon / Feb 7th
Flora Growth Corp. submitted an application to Colombian regulators for researching whether a cannabinoid-based product can help prevent COVID-19 infections.
Fri / Jan 21st
The University of Mississippi launched the National Center for Cannabis Research and Education to conduct scientific research and aid in policymaking and legalization-related outreach.
Wed / Jan 19th
According to a recent survey, respondents between the ages of 18 to 30 who use cannabis and alcohol have better sexual functions and orgasms than those that don’t consume either.
Thu / Jan 13th
A new survey found 88.8% of patients with a skin condition would try a medical cannabis-based treatment.
Tue / Jan 11th
Researchers at the University of Mississippi have been awarded $1.37 million to study if cannabis can help manage HIV-related pain in patients.
Mon / Jan 10th
The biotech pharma firm ANANDA Scientific Inc. announced it has received FDA approval to study a CBD-based drug as a treatment for opioid-use disorder.
Fri / Jan 7th
Groff North America Hemplex and BRC, two cannabis cultivation firms, have harvested federally sanctioned cannabis for research purposes, ending a 50-year monopoly by the University of Mississippi.
Mon / Jan 3rd
A recent study found significant improvement in autism symptoms following treatment with THC-rich cannabis oil.
Fri / Dec 31st
A recent study found that cannabis decriminalization policies have helped to reduce the racial disparity in cannabis possession arrests.
Wed / Dec 22nd
A set of GOP companion bills in the House and Senate seeking to curb illegal fentanyl sales would also streamline the research of cannabis, psychedelics, and other Schedule I substances.
Tue / Dec 7th
Researchers at the University of Sydney in Australia have found that blood and oral fluid THC concentrations are weak indicators of cannabis-induced impairment.
Mon / Dec 6th
A new study found that psilocybin may be able to reverse alcohol brain damage, reduce alcohol-addictive behavior, and reduce relapse rates.
Fri / Nov 5th
NORML released an updated and revised version of “Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000-2021.” Proceeds from the book will be used to fund NORML’s advocacy efforts.
Mon / Nov 1st
A recent survey found 65% of patients were able to reduce or eliminate taking at least one prescription medication after obtaining their medical cannabis registration.
Fri / Oct 22nd
Baltimore’s Johns Hopkins Medicine announced that the National Institutes of Health will provide nearly $4 million to help researchers study how psilocybin can affect tobacco addiction.
Thu / Oct 21st
Bank of America suddenly canceled the account of cannabis research firm Scottsdale Research Institute despite being fully compliant with federal laws and operating with public DEA approval.
Mon / Oct 18th
The DEA has proposed massively increasing the production of research-grade cannabis and psychedelics like LSD, psilocybin, and MDMA next year.
Tue / Sep 28th
Researchers found that less than 2% of people living in states that have legalized cannabis have been diagnosed with “cannabis use disorder” and that the reforms were not linked to increased cannabis consumption among youths aged 12-20.
Tue / Sep 28th
A recent survey found that 60% of cannabis consumers said they would consume cannabis with their grandparents.
Mon / Sep 20th
Researchers found that withdrawal effects from synthetic cannabinoids appear more rapidly with consumers reporting more severe symptoms of insomnia, irritation and bad mood, heart palpitations, and loss of appetite.
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.